TREM2 and Sepsis: Furthermore, the influence of pathology-driven changes in blood composition, particularly in conditions with strong systemic inflammation (e.g., sepsis), in which altered leukocyte dynamics and soluble TREM2 levels may impact tracer distribution, is a potential limitation.